Indianapolis, Indiana – Lilly has announced the acquisition of Adverum Biotechnologies (https://adverum.com/). According to the company announcement Lilly is a medicine company dedicated to transforming scientific discoveries into healing solutions to improve the lives of people globally. For nearly 150 years, the company has been at the forefront of life-changing breakthroughs, and its medicines currently benefit tens of millions of individuals worldwide. By leveraging the capabilities of biotechnology, chemistry, and genetic medicine, Lilly’s scientists are actively pursuing new discoveries to address some of the world’s most critical health issues. Their focus areas include redefining diabetes care, combating obesity and its long-term consequences, fighting Alzheimer’s disease, treating debilitating immune system disorders, and making difficult-to-treat cancers manageable. Lilly is driven by the goal of enhancing the lives of millions more people, which involves conducting innovative clinical trials that represent global diversity and striving to make its medicines both accessible and affordable.

To learn more about Lilly, visit https://www.lilly.com/
Company LinkedIn Page: https://www.linkedin.com/company/eli-lilly-and-company/

Company Contact:

Lilly
Lilly Corporate Center Indianapolis, IN 46285
317-276-2000

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.